Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

"The approach of using benfotiamine in patients with mild Alzheimer's is very promising," said Rajiv Ratan, M.D., Ph.D., Executive Director at Burke Neurological Institute. "This clinical trial builds ...

When Jonel first noticed she was having trouble moving her hands, a diagnosis of Alzheimer’s disease never crossed her mind.

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...

We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for ...

Blocking calcium channels in brain capillaries may enhance blood flow and alleviate early-stage Alzheimer's damage, new study ...

New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.

signature in Alzheimer's Disease (AD). They also investigated miRNAs that could predict the transition from mild cognitive ...

Around 55 million people globally are affected by dementia, with Alzheimer's disease responsible for 70% of these cases. The ...

The results from the statistical analysis suggest certain shared genes play a role in Alzheimer's, heart disease traits such ...

A new study provides important insight into how amyloid-beta and tau proteins impact brain activity and possibly contribute to cognitive decline in Alzheimer's disease.